IFIT3 Is Increased in Serum from Patients with Chronic Hepatitis B Virus (HBV) Infection and Promotes the Anti-HBV Effect of Interferon Alpha via JAK-STAT2 In Vitro

Increasing evidence indicates that interferon alpha (IFN-α) therapy is an effective treatment option for a subgroup of patients with chronic hepatitis B virus (HBV) infection. It has been confirmed that interferon-induced protein with tetratricopeptide repeats 3 (IFIT3), a member of the interferon-s...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Siyi, Huang, Jinlan, Xun, Zhen, Li, Shiqi, Fu, Ya, Lin, Ni, Wu, Wennan, Chen, Tianbin, Liu, Can, Ou, Qishui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769971/
https://www.ncbi.nlm.nih.gov/pubmed/36314949
http://dx.doi.org/10.1128/spectrum.01557-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769971/
https://www.ncbi.nlm.nih.gov/pubmed/36314949
http://dx.doi.org/10.1128/spectrum.01557-22

Ejemplares similares